HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gunnar Kvalheim Selected Research

LTX-315

1/2019Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model.
1/2017Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gunnar Kvalheim Research Topics

Disease

32Neoplasms (Cancer)
01/2021 - 11/2004
10Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2003
8Melanoma (Melanoma, Malignant)
01/2021 - 06/2005
5Lymphoma (Lymphomas)
01/2021 - 11/2004
5Breast Neoplasms (Breast Cancer)
08/2012 - 11/2004
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 06/2011
3Infections
01/2021 - 01/2011
3Hypersensitivity (Allergy)
01/2016 - 01/2011
2Colorectal Neoplasms (Colorectal Cancer)
04/2020 - 01/2017
2Carcinoma (Carcinomatosis)
04/2020 - 04/2005
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 11/2003
2Hypoxia (Hypoxemia)
01/2017 - 01/2011
2Neoplasm Metastasis (Metastasis)
01/2016 - 01/2003
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2015 - 03/2011
2Leukemia
10/2014 - 07/2007
2Graft vs Host Disease (Graft-Versus-Host Disease)
09/2014 - 01/2011
1B-Cell Leukemia (Leukemia, B Cell)
01/2021
1Ascites
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019
1Triple Negative Breast Neoplasms
01/2019
1Microsatellite Instability
01/2017
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2017
1Stomach Neoplasms (Stomach Cancer)
01/2017
1Sarcoma (Soft Tissue Sarcoma)
01/2017
1Fibrosarcoma
01/2017
1Colonic Neoplasms (Colon Cancer)
01/2017
1Wilms Tumor (Wilm's Tumor)
10/2014
1Residual Neoplasm
10/2014
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2014
1Glioblastoma (Glioblastoma Multiforme)
09/2013
1Brain Neoplasms (Brain Tumor)
09/2013
1Nervous System Diseases (Neurological Disorders)
05/2013
1Lung Neoplasms (Lung Cancer)
01/2013
1Neutropenia
06/2011
1Bites and Stings (Sting)
05/2011
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2011
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2011

Drug/Important Bio-Agent (IBA)

10Messenger RNA (mRNA)IBA
01/2016 - 04/2005
8VaccinesIBA
01/2022 - 06/2005
8Peptides (Polypeptides)IBA
01/2021 - 12/2006
8AntigensIBA
01/2021 - 06/2005
7CytokinesIBA
01/2021 - 05/2007
5Proteins (Proteins, Gene)FDA Link
01/2017 - 04/2005
4Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021 - 12/2006
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021 - 01/2017
3Mitochondrial DNA (mtDNA)IBA
08/2017 - 08/2013
2CD19 AntigensIBA
01/2021 - 01/2019
2LTX-315IBA
01/2019 - 01/2017
2Chimeric Antigen ReceptorsIBA
01/2019 - 05/2011
2Interleukin-8 (Interleukin 8)IBA
01/2017 - 11/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 11/2005
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2017 - 11/2005
2EpitopesIBA
01/2016 - 06/2011
2SurvivinIBA
01/2016 - 07/2013
2Rituximab (Mabthera)FDA Link
01/2015 - 03/2011
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2015 - 12/2006
2RNA (Ribonucleic Acid)IBA
10/2014 - 06/2005
2Cancer VaccinesIBA
07/2013 - 06/2005
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
08/2012 - 11/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2020
1Epithelial Cell Adhesion MoleculeIBA
04/2020
1Immunotoxins (Immunotoxin)IBA
04/2020
1SolutionsIBA
02/2019
1invariant chain (Ii-Key)IBA
01/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1AlarminsIBA
01/2019
1alvocidib (flavopiridol)IBA
11/2017
1Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2017
1Ethidium (Ethidium Bromide)IBA
08/2017
1AutoantigensIBA
01/2017
1Differentiation AntigensIBA
01/2017
1AdenineFDA LinkGeneric
01/2017
1Antigen Receptors (Antigen Receptor)IBA
01/2017
1Conditioned Culture MediaIBA
01/2017
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2017
1Streptozocin (Streptozotocin)FDA Link
01/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017
1IpilimumabIBA
01/2016
1Interleukin-3 (Interleukin 3)IBA
12/2015
1CarcinogensIBA
12/2015
1InterleukinsIBA
12/2015
1SuspensionsIBA
09/2013
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
07/2013
1AntibodiesIBA
06/2013
1Histone Deacetylases (Histone Deacetylase)IBA
05/2013
1AndrogensIBA
01/2013
1Anti-Allergic Agents (Antiallergic Agents)IBA
01/2011

Therapy/Procedure

11Therapeutics
01/2021 - 01/2003
10Immunotherapy
01/2021 - 06/2011
7Drug Therapy (Chemotherapy)
01/2019 - 11/2004
4Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021 - 01/2016
4Radiotherapy
01/2015 - 11/2005
2Injections
01/2015 - 11/2004
2Stem Cell Transplantation
01/2011 - 11/2003
1Prostatectomy (Retropubic Prostatectomy)
01/2022
1Surgical Instruments (Clip)
01/2019
1Transplantation
09/2014
1Neoadjuvant Therapy
08/2012
1Traditional Medicine (Folk Remedies)
01/2011